2004 Annual Meeting | Vascular Dementia and Vascular Cognitive Impairment: Advances in Diagnosis and Treatment

Date Friday 04/30/04

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) Gustavo C. Roman, MD, FAAN

Topic(s) Aging/Dementia/Degenerative Disease

Learning Objectives Upon completion:
Participants should become familiar with the evolution of the concepts and clinical spectrum of vascular dementia and vascular cognitive impairment; the strengths and limitations of the diagnostic criteria for vascular dementia and vascular cognitive impairment; and understand new data about risk factor modifying and cognitive enhancing treatments for vascular dementia.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse, Other

Event Timeline
07:00 PM - 07:30 PM		Vascular Dementia: Introduction and Concepts Gustavo C. Roman, MD, FAAN
07:30 PM - 08:00 PM		Diagnosis and Pathogenesis of Vascular Dementia Helena C. Chui, MD
08:00 PM - 08:30 PM		Treatment and Prevention of Vascular Dementia Stephen P. Salloway, MD, MS
08:30 PM - 09:30 PM		Discussion

Faculty Disclosures
	No disclosure on file
Stephen P. Salloway, MD, MS	Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NovoNordisk. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurophet. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kisbee. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CognitionRX. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck.
Helena C. Chui, MD	The institution of Dr. Chui has received research support from National Institute on Aging .
Gustavo C. Roman, MD, FAAN	The institution of Dr. Roman has received research support from Brain Chamistry Labs.

��ɫ��

��ɫ��